_aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompen...

_aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompen... _aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompensation LH rises when androgen output is low due to lower Leydig cell sensitivity GH rises when the liver its output of IGF-1 is low or disrupted, this is why it rises when Insulin drops, Insulin is Show more _aestheticprimal_ @aestheticprimal Jul 22 high LH levels are not indicative of a well functioning HPG axis It shows how the Leydig cells need excessive stimulation to make up for reduced sensitivity Its sensitivity is dependent on circadian rhythm, output of adrenals and pituitary as well as oxidative stress 1 6 1.5K

_aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompen... _aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompensation LH rises when androgen output is low due to lower Leydig cell sensitivity GH rises when the liver its output of IGF-1 is low or disrupted, this is why it rises when Insulin drops, Insulin is Show more _aestheticprimal_ @aestheticprimal Jul 22 high LH levels are not indicative of a well functioning HPG axis It shows how the Leydig cells need excessive stimulation to make up for reduced sensitivity Its sensitivity is dependent on circadian rhythm, output of adrenals and pituitary as well as oxidative stress 1 6 1.5K

_aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompen... _aestheticprimal_ @aestheticprimal 29m GH follows the same pattern as LH, in the way it rises in effort of overcompensation LH rises when androgen output is low due to lower Leydig cell sensitivity GH rises when the liver its output of IGF-1 is low or disrupted, this is why it rises when Insulin drops, Insulin is Show more _aestheticprimal_ @aestheticprimal Jul 22 high LH levels are not indicative of a well functioning HPG axis It shows how the Leydig cells need excessive stimulation to make up for reduced sensitivity Its sensitivity is dependent on circadian rhythm, output of adrenals and pituitary as well as oxidative stress 1 6 1.5K

Anecdotal claim: a client reports improved nocturia/sleep continuity after taking 20mg vitamin K2 (MK-4) before bed for 4 days. No clinical data, no identifiable public-company catalyst, and unclear market relevance.

Content discusses human endocrinology (GH/LH/IGF-1, insulin, Leydig cell sensitivity, HPG axis) and makes no explicit market, company, sector, macro, or investable-asset claims. Not directly translatable into a tradable catalyst without additional context (e.g., drug/company linkage, clinical results, regulation, product demand).

A social-media joke/comment about progesterone and relationship behavior; no financial, economic, or market-relevant information.

Anecdotal social post claims higher-dose Vitamin K2 (MK-4) plus Vitamin E (mixed tocopherols) improved testosterone/LH dynamics, with commentary that high LH can indicate reduced Leydig-cell sensitivity and oxidative stress/circadian factors. This is not investable as a catalyst by itself, but it loosely reinforces an existing supplement/ingredients demand narrative (fat-soluble vitamins, antioxidant positioning).

Commentary about an unspecified substance reducing FSH and LH modestly, in a dose-dependent manner. No company, drug, catalyst, or tradable asset is identified.

Discussion about physiological effects of topical testosterone and DHT on HPG axis activity; no explicit market, company, product, or investable asset referenced.

The source only states that the user has heard “tons of strong reviews” about @JK99928789839, with no identifiable company/ticker, product, catalyst, timeframe, or tradable implication.

Non-financial social post about skincare/sun exposure increasing skin sensitivity; no market, company, or asset implications.